Alan Melcher

16.6k citations
250 papers · 11.0k · 1 hit paper · h-index 61

Impact in

  • Oncology top 0.2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Genetics top 0.1%
    • Virus-based gene therapy research

Papers in

    • Virus-based gene therapy research 146
    • CAR-T cell therapy research 70
    • Cancer Immunotherapy and Biomarkers 28

Alan Melcher

244 papers receiving 10.7k citations

Alan Melcher's Hit Papers

Inflammatory microenvironment remodelling by tumour cells after radiotherapy 2020 · 633 citations
6330+2+4Years since publication200400600

Peers

Alan Melcher
Comparison fields: 5 of 124
  • Oncology 5.1k
  • Genetics 5.5k
  • Immunology 3.4k
  • Biotechnology 1.3k
  • Infectious Diseases 1.6k
Replace Richard G. Vile with:
Richard G. Vile United States
Hardev Pandha United Kingdom
Akseli Hemminki Finland
Ramón Alemany Spain
Patrick W.K. Lee Canada
Jean Rommelaere Germany
Dmitriy Zamarin United States
J. Ignacio Casal Spain
Nancy C. Reich United States
Alex J. van der Eb Netherlands
Alan Melcher relative to Richard G. Vile United States Richard G. Vile's profile →
Citations per field
00.5×1.5×
Richard G. Vile · 1×
Citations per year

Countries citing papers authored by Alan Melcher

Since Specialization
Citations

This map shows the geographic impact of Alan Melcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Melcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Melcher more than expected).

Fields of papers citing papers by Alan Melcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Melcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Melcher. The network helps show where Alan Melcher may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Melcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Melcher Line = papers co-authored together Alan Melcher links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Hit paper breakdown →
2020633
2 1998404
3 1999288
4 2008197
5 2011196
6 2018168
7 2009167
8 2011161
9 2012160
10 2015158
11 2008156
12 2008156
13 2008156
14 2019152
15 2008148
16 2009145
17 2009144
18 2011134
19 2008129
20 2007121

About Alan Melcher

Alan Melcher is a scholar working on Genetics, Oncology, Immunology, Molecular Biology and Biotechnology, having authored 250 papers that have together received 11.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (146 papers), CAR-T cell therapy research (70 papers), Immunotherapy and Immune Responses (54 papers), Cancer Research and Treatments (48 papers), Viral gastroenteritis research and epidemiology (38 papers), Cancer Immunotherapy and Biomarkers (28 papers), RNA Interference and Gene Delivery (24 papers) and Immune Cell Function and Interaction (16 papers). The work is most often cited by research in Oncology (5.1k citations), Genetics (5.5k citations), Immunology (3.4k citations), Biotechnology (1.3k citations) and Infectious Diseases (1.6k citations). Alan Melcher has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Richard G. Vile, Kevin J. Harrington, Hardev Pandha, Fiona Errington‐Mais, Peter J. Selby, Timothy Kottke, Jill Thompson, Robin Prestwich, Rosa María Díaz and Stephen Todryk. Their work appears in journals such as Molecular Therapy, Clinical Cancer Research, Gene Therapy, Journal of Clinical Oncology and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact